Two Sigma Investments, LP Novo Cure LTD Call Options Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2021 Nov 15, 2021	SELL	$116.17 - $194.55 $313,659 - $525,285	-2,700 Reduced 18.88%	11,600 $1.35 Million
Q1 2021 May 17, 2021	BUY	$124.11 - $190.17 $1.3 Million - $2 Million	10,500 Added 276.32%	14,300 $1.89 Million
Q4 2020 Feb 16, 2021	SELL	$112.16 - $174.14 $1.03 Million - $1.6 Million	-9,200 Reduced 70.77%	3,800 $658,000
Q2 2020 Aug 14, 2020	SELL	$57.2 - $74.41 $308,880 - $401,814	-5,400 Reduced 29.35%	13,000 $771,000
Q1 2020 May 15, 2020	BUY	$57.05 - $95.75 $844,340 - $1.42 Million	14,800 Added 411.11%	18,400 $1.24 Million
Q4 2019 Feb 14, 2020	SELL	$68.3 - $93.8 $1.86 Million - $2.56 Million	-27,300 Reduced 88.35%	3,600 $303,000
Q3 2019 Nov 14, 2019	BUY	$61.86 - $97.8 $1.66 Million - $2.63 Million	26,900 Added 672.5%	30,900 $2.31 Million
Q2 2019 Aug 14, 2019	BUY	$42.22 - $63.23 $168,880 - $252,920	4,000 New	4,000 $253,000

263

77M

1.17M

318K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.16B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.